As of 2025-09-18, the Intrinsic Value of BetterLife Pharma Inc (BETR.CN) is -0.06 CAD. This BETR.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.09 CAD, the upside of BetterLife Pharma Inc is -169.15%.
Based on its market price of 0.09 CAD and our intrinsic valuation, BetterLife Pharma Inc (BETR.CN) is overvalued by 169.15%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.06 - -0.06 | -0.06 | -169.15% |
| DDM - Stable | (0.12) - (0.69) | (0.41) | -576.8% |
| DDM - Multi | (0.77) - (3.44) | (1.27) | -1599.2% |
| Market Cap (mil) | 12.91 |
| Beta | 0.63 |
| Outstanding shares (mil) | 151.84 |
| Enterprise Value (mil) | 13.81 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.10% |
| Cost of Debt | 5.00% |
| WACC | 7.81% |